iRhythm Technologies, Inc.
IRTCNASDAQHealthcare● Active
$110.51
+$2.41(+2.22%)
Market Cap$3.6B
P/E Ratio—
52W High$212
52W Low$101.75
iRhythm Technologies, Inc. (IRTC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IRTC · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.75B | $0.59B | $0.49B | $0.41B | $0.32B |
| Cost of Revenue | $0.22B | $0.18B | $0.16B | $0.13B | $0.11B |
| Gross Profit | $0.53B | $0.41B | $0.33B | $0.28B | $0.21B |
| Gross Margin %(computed) | 70.57% | 68.86% | 67.35% | 68.54% | 66.16% |
| Operating Expenses | |||||
| R&D Expenses | $0.08B | $0.10B | $0.06B | $0.05B | $0.04B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.56B | $0.52B | $0.46B | $0.40B | $0.31B |
| Operating Income | ($0.04B) | ($0.12B) | ($0.13B) | ($0.11B) | ($0.10B) |
| Operating Margin %(computed) | -4.93% | -19.52% | -25.40% | -27.69% | -30.96% |
| Interest Income | $0.02B | $0.02B | $0.01B | $0.00B | $0.00B |
| Interest Expense | $0.01B | $0.01B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.04B) | ($0.11B) | ($0.12B) | ($0.12B) | ($0.10B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.04B) | ($0.11B) | ($0.12B) | ($0.12B) | ($0.10B) |
| Net Margin %(computed) | -5.96% | -19.14% | -25.05% | -28.27% | -31.40% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.39 | $-3.63 | $-4.04 | $-3.88 | $-3.46 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| EBITDA | ($0.01B) | ($0.07B) | ($0.10B) | ($0.09B) | ($0.08B) |
| EBITDA Margin %(computed) | -1.38% | -12.52% | -19.66% | -22.42% | -25.78% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more iRhythm Technologies, Inc. data
About iRhythm Technologies, Inc. (IRTC) Income Statement
iRhythm Technologies, Inc. (IRTC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, IRTC reported revenue of $0.75B, gross profit of $0.53B (gross margin 70.57%), and net income of ($0.04B) — a net profit margin of -5.96%.
Frequently asked questions
IRTC · 4 questionsiRhythm Technologies, Inc. (IRTC) reported revenue of $0.75B for 2025, up 26.2% year-over-year.
IRTC revenueIRTC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08